Boehringer Ingelheim Wins Pradaxa Wrongful Death Suit
A Georgia federal judge has cleared Boehringer Ingelheim Pharmaceuticals Inc. from a wrongful death suit alleging it failed to warn about the bleeding risks of its blood thinner Pradaxa, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article